The Latest Cardiac and Vascular News
ABBOTT PARK, Ill., July 18, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the second quarter ended June 30, 2018. Second-quarter worldwide sales of $7.8 billion increased 17.0 percent on a reported basis and 8.0 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.40 in the second quarter. Adjusted diluted EPS […]
ATLANTA, July 18, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 second quarter financial results will be released on Monday, August 6, 2018 after the market closes. On Tuesday, August 7, 2018 the Company will hold a teleconference call and live webcast at 8:30 […]
INDIANAPOLIS, July 18, 2018 /PRNewswire/ — Cook Regentec announced today the first clinical use in the United Statesof the Advance CS Coronary Sinus Infusion Catheter and Compass® CT Disposable Pressure Transducer to deliver a therapeutic in heart failure patients. The Advance CS Coronary Sinus Infusion Catheter is a percutaneous balloon infusion catheter designed […]
BERLIN–(BUSINESS WIRE)–OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular and ophthalmic diseases, today announced results from its first-in-human clinical study for OMT-28. The study met its primary goal with OMT-28 exhibiting an excellent tolerability profile and showing no safety signals […]
NEW YORK and MELBOURNE, Australia, July 17, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that it has entered into a strategic alliance with one of China’s largest pharmaceutical companies, Tasly Pharmaceutical Group (SHA: 600535; Tasly), for the development, manufacture and commercialization in China of Mesoblast’s allogeneic mesenchymal precursor cell […]
MALVERN, Pa., July 17, 2018 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2018 earnings on Wednesday, July 25 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, July 25, 2018. The broadcast will be available through […]
Lausanne, Switzerland and Palo Alto, USA, July 17, 2018 / B3C newswire / — Polares Medical SA, a preclinical stage medical technology company focused on the development of a unique trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR), announced today the closing of a $25 million […]
SANTA CLARA, Calif., July 17, 2018 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare devices, today announces exciting solutions built on its developer program. VivaLNK’s developer program enables Internet of Health Things (IoHT) solution providers to easily integrate medical and healthcare applications with VivaLNK’s suite of connected wearable devices for wellness, remote […]
SAN DIEGO, July 15, 2018 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, is expanding commercial access to the Fantom® Bioresorbable Scaffold with a new distribution partnership in Italy. REVA will work with Bio Vascular Group S.R.L. (“Bio Vascular”) […]
SOUTH JORDAN, Utah, July 16, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the […]
